While the coronavirus has impacted millions of Americans across the United States, it has hit the elderly population particularly hard. In fact, more than 40 percent of coronavirus deaths in the U.S. have been linked to long-term care facilities, according to a New York Times survey. In an effort to bring those numbers down, pharmaceutical company Eli Lilly, in partnership with the National Institutes of Health (NIH), has just launched a late-stage antibody treatment trial focusing on residents and staff at nursing homes.
"COVID-19 has had a devastating impact on nursing home residents," Lilly's chief scientific officer Daniel Skovronsky said in a statement. "We're working as fast as we can to create medicines that might stop the spread of the virus to these vulnerable individuals."
The trial is expected to enroll up to 2,400 participants who live or work at a facility and have recently been diagnosed with the disease. The trial will evaluate the safety and success of using LY-CoV555, a potent, neutralizing antibody that works against the spike protein of the novel coronavirus. The trial will look at whether a single dose of the antibody treatment reduces the rate of infection over four weeks as well as symptoms over eight weeks.
"The importance of these kinds of therapies for people like the elderly or immunocompromised is that they can provide the hope and the safety net that these people really need right now," said Andrew Adams, vice president of new therapeutic modalities & COVID-19 research at Eli Lilly, who is overseeing the trial. "I think people in those populations are really desperate and looking for something to help with the coronavirus."
Eli Lilly is taking its trial on the road with customized mobile research units that can travel directly to areas that are experiencing outbreaks.
"This is an interesting solution, to bring the medicine to these vulnerable patients," said Adams. "This lets us be flexible and move these trials around the country, tracking these trials as we come across them."
Adams said he is hoping Eli Lilly will have results on the efficacy of these antibodies in the fourth quarter of this year. Even if successful, though, he says research for a vaccine needs to continue.
"These have to be thought of as more of a bridge, where a vaccine provides long-term protection in terms of years of immunity, where we will provide hopefully in the range of months with these types of treatments. We hope this to be a short-term bridge to the long-term effective vaccination," he said.
Jill and Carlo discuss the pending approval for Pfizer's vaccine for kids, the state of anti-Semitism three years after Tree of Life, potential criminal charges in the 'Rust' prop gun shooting and more.
Amalgamated Bank is the first U.S. bank to publish science-based targets to reach net-zero greenhouse gas emissions by 2045. The bank says it will reach this goal through how it engages with customers and how it finances projects. Amalgamated Bank Chief Sustainability Officer Ivan Frishberg joined Cheddar Climate to provide more details about the bank's ambitious climate goals.
COP26 been dealt a blow as Chinese President Xi Jinping and Russian President Vladimir Putin, whose countries are responsible for a third of the world's annual greenhouse gas emissions, will not be in attendance. Bertrand Piccard, Chairman and Founder of the Solar Impulse Foundation, joins Cheddar Climate, where he discusses what he expects to see when the summit commences in Glasgow.
John Nosta, WHO Technology Expert, joins Cheddar News to discuss evolving technology in the healthcare industry and the role 5G is playing in advancing healthcare delivery.
According to the latest report from the UN, several countries around the world are "nowhere near" towards their goal of limiting gas emissions. This report comes ahead of the COP26 which is slated to take place in the month of November in Scotland. Senior Advisor at CDP Paula Diperna, joined Cheddar to discuss what the report highlights and what this tells us about the future plans of the Paris Climate Agreement.
Powerful weather systems over California have caused record amounts of rainfall in the state, including over wildfire-scorched lands since triggering massive landslides.
The FDA meets today on whether or not vaccines for children ages 5-11 can potentially become available to the public. Cheddar News was joined by Dr. Richard Besser, President and CEO of the Robert Wood Johnson Foundation and former Acting Director of the CDC to discuss what could come next for these vaccines.
Dan DePodwin, Director of Forecasting Operations at AccuWeather, joined Wake Up With Cheddar to talk about the extreme weather across the country, including damaging rains in the drought-stricken western U.S. and an incoming Nor'easter that's likely to cause flooding and power outages along the Atlantic coast.
Jill and Carlo cover the news out of Facebook's latest earnings, Tesla's monumental day, Dave Chappelle addresses controversy and the tragedy of the climate emergency.
The UN's World Meteorological Organization reported that carbon dioxide in the atmosphere hit record levels in 2020, despite coronavirus-related lockdowns. With the COP26 international meeting on climate change less than a week away, Risk and behavioral scientist Dr. Sweta Chakraborty joined Cheddar to break down the "code red for humanity" the report represents and what actual commitments must be made to prevent significant global temperature increases.
